Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 7
211
Views
12
CrossRef citations to date
0
Altmetric
Short Communications

Identification of anti-nociceptive constituents from the pollen of Typha angustifolia L. using effect-directed fractionation

, , , , ORCID Icon &
Pages 1041-1045 | Received 05 Sep 2018, Accepted 21 Oct 2018, Published online: 23 Dec 2018
 

Abstract

The pollen of T. angustifolia, also known as Pu huang in Chinese, has been used for treatment of stranguria, hematuria, dysmenorrhea, metrorrhagia and injuries in China for a long time. Extensive efforts have been directed toward its phytochemical and biological aspects. However, little is known about its anti-nociceptive implication and material basis. This work presented the investigation of the anti-nociceptive effect of Typhae Pollen using an effect-directed fractionation strategy, thereby leading to identification of isorhamnetin-3-O-neohesperidin (1) and typhaneoside (2), together with other minor flavonoid glycoside congeners, as the main anti-nociceptive constituents. This work not only unveils the anti-nociceptive potential of Typhae Pollen, but also establishes a method to enrich and identify the anti-nociceptive constitutes of Typhae Pollen. Moreover, this work is a successful example of effect-directed fractionation strategy, which represents a powerful tool in TCM-based drug discovery and development.

Disclosure statement

The authors declare no conflicts of interest.

Additional information

Funding

This work was supported by the [National Natural Science Foundation of China] under Grant [21302193 and 81573314]; [Nature Science Foundation of Hunan Province] under Grant [2018JJ3707]; [Changsha Science and Technology Projects] under Grant [kq1701088]; and [Foundation of Hunan Educational committee] under Grant [16C1214].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.